Stocks Reporter Aug stock pick—MBRA

Company Profile

Since 1971, Biomerica has developed, manufactured, and distributed medical diagnostic products for the early detection and monitoring of chronic diseases and certain medical conditions. 

The Company’s test kits and devices are sold in three markets:
· Clinical laboratories
· Physician’s offices
· Over-the-counter (pharmacies)

Biomerica is proud of its history of product innovation spanning more than three decades in several major clinical areas.  It was the first Company to manufacture and market tests for:
· Myoglobin (Cardiac)
· H. Pylori (Digestive Disease)
· Histamine (Allergy)
· Self test for Colon Disease (Digestive)
· Early detection of Diabetes (Diabetes)

All of our products are CE marked for European sales and manufactured under EN ISO 13485 certification. 

The Biomerica main campus occupies an area of over 25,000 square feet in beautiful Newport Beach, California.  This complex houses the company’s headquarters, including administrative offices, laboratories, and FDA registered manufacturing facilities.

Biomerica, Inc. also operates a 10,000 square foot production facility in Mexicali, Mexico.  Like the US headquarters, the Mexico facility is both EN ISO 13485 and FDA certified.

Stocks Reporter.com has received no compensation in the form of cash or securities for coverage and has no position of MBRA shares.

Report Page 2

MBRA Forum